Auvelity ER 45-105 MG tablet UU 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F0ZX5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,027
Award facts
- Contract value 100% obligated
- $18,027.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 13, 2026, the Defense Logistics Agency awarded a delivery order valued at $18,027.20 to AmerisourceBergen Drug Corp for the supply of Auvelity ER 45-105 mg tablets in quantities of 60 units. The contract represents a firm fixed-price delivery order with an ultimate completion date of January 14, 2026, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This award was not set aside for any specific business category and was competitively awarded through the DLA's procurement processes. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as a major pharmaceutical distributor and critical vendor for federal medical procurement needs, particularly supporting military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. Auvelity, a combination antidepressant medication containing doxepin and bupropion, represents one of the specialized pharmaceutical products within the broader portfolio of medications and medical commodities provided under this strategic contract vehicle.
Quick answers
Who was awarded contract SPE2DR26F0ZX5?
SPE2DR26F0ZX5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F0ZX5 worth?
The government has obligated $18,027 on SPE2DR26F0ZX5.
Is contract SPE2DR26F0ZX5 an order under another contract?
Yes. SPE2DR26F0ZX5 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F0ZX5 competed?
The extent of competition for SPE2DR26F0ZX5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award